Filana Therapeutics (PX91.STU) Q2 2026 Earnings

7MayConfirmed
Q2 2026
-0.2
-0.19
-0.18
-0.18

Details

Expected EPS
-0.1961141
Actual EPS
-0.1790607
Surprise EPS
0.02
Surprise Percent
+8.7%

Description

Filana Therapeutics (PX91.STU) has reported earnings of -0.1790607 per share for Q2 2026.

0 Comments

Share your thoughts